1. 20. Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis. (4th December 2021) Authors: Zamora, Danniel; Perchetti, Garrett; Biernacki, Melinda; Xie, Hu; Castor, Jared L; Joncas-schronce, Laurel; Blazevic, Rachel; Leisenring, Wendy; Huang, Meei-Li; Jerome, Keith; Martin, Paul J; Boeckh, Michael; Greninger, Alexander L Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗